Intensified doxorubicin-based regimen efficacy in residual non-Hodgkin's lymphoma disease: towards a computationally supported treatment improvement (Q2788513)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Intensified doxorubicin-based regimen efficacy in residual non-Hodgkin's lymphoma disease: towards a computationally supported treatment improvement |
scientific article; zbMATH DE number 6543002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intensified doxorubicin-based regimen efficacy in residual non-Hodgkin's lymphoma disease: towards a computationally supported treatment improvement |
scientific article; zbMATH DE number 6543002 |
Statements
19 February 2016
0 references
mathematical model
0 references
vascular tumour
0 references
avascular tumour
0 references
heterogeneity
0 references
chemotherapy
0 references
non-Hodgkin lymphoma
0 references
CHOP
0 references
doxorubicin
0 references
hybrid cellular automata
0 references
0 references
Intensified doxorubicin-based regimen efficacy in residual non-Hodgkin's lymphoma disease: towards a computationally supported treatment improvement (English)
0 references
